Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study

被引:98
作者
Cuspidi, C
Muiesan, ML
Valagussa, L
Salvetti, M
Di Biagio, C
Agabiti-Rosei, E
Magnani, B
Zanchetti, A
机构
[1] Univ Milan, Osped Maggiore, Ist Clin Med & Terapia Med, Milan, Italy
[2] Univ Milan, Osped Maggiore, Ctr Fisiol Clin & Ipertens, Milan, Italy
[3] Ist Auxol Italiano, Milan, Italy
[4] Univ Brescia, Clin Med Interna, Dipartimento Sci Med & Chirurg, Brescia, Italy
[5] Univ Bologna, Takeda Italia, Bologna, Italy
[6] Univ Bologna, Ist Cardiol, Bologna, Italy
关键词
hypertension; hypertrophy; echocardiography; drugs;
D O I
10.1097/00004872-200211000-00030
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background A limited number of studies have evaluated the effect of angiotensin 11 receptor antagonists (AllAs) on left ventricular hypertrophy (LVH) in comparison with other antihypertensive drugs, and no large study has compared AllAs with angiotensin-converting enzyme inhibitors (ACEIs). Methods and results The CATCH (Candesartan Assessment in the Treatment of Cardiac Hypertrophy) study was a multicenter prospective randomized double-blind trial comparing the effects of candesartan cilexetil (8-16 mg once daily) and enalapril (10-20 mg once daily) with possible addition of hydrochlorothiazide (12.5-25 mg once daily) on echocardiographic left ventricular mass index (LVMI), in 239 hypertensives with LVH (LVMI > 120 g/m(2) in men and > 100 g/m(2) in women). Two-dimensionally guided M-mode echocardiograms were carried out at screening (recruiting scan), randomization (baseline scan) and after 24 and 48 weeks of treatment. Baseline and treatment echocardiograms were read at two central labs without knowledge of the scan time sequence. In intention-to-treat (ITT) analyses (196 patients), systolic and diastolic blood pressures (SBP, DBP) were significantly and equally reduced by the two treatments. Candesartan and enalapril reduced LVMI to the same extent, i.e. by 15.0 and 13.1 g/m(2) (-10.9 and -8.4%; < 0.001 for both). The proportion of patients achieving normalization of LVMI was non-significantly higher with candesartan (36.3 versus 28.6%). Similar results were obtained in per-protocol (PP) analyses. Cough incidence was lower with candesartan (P < 0.03). Conclusions CATCH is the first large study comparing the effects of an AIIA and an ACEI on LVMI. Candesartan cilexetil was found to be equally effective as enalapril in reducing SBP, DBP and LVMI in hypertensives with LVH, according to both ITT and PP analyses. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:2293 / 2300
页数:8
相关论文
共 31 条
[1]   ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study [J].
AgabitiRosei, E ;
Ambrosioni, E ;
DalPalu, C ;
Muiesan, ML ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 1995, 13 (11) :1325-1334
[2]  
CRUICKSHANK JM, 1992, J HUM HYPERTENS, V6, P85
[3]   Left ventricular hypertrophy and angiotensin II antagonists [J].
Dahlöf, B .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (02) :174-182
[4]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[5]   REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES [J].
DAHLOF, B ;
PENNERT, K ;
HANSSON, L .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) :95-110
[6]   REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN PREVIOUSLY UNTREATED ESSENTIAL-HYPERTENSION - DIFFERENT EFFECTS OF ENALAPRIL AND HYDROCHLOROTHIAZIDE [J].
DAHLOF, B ;
HANSSON, L .
JOURNAL OF HYPERTENSION, 1992, 10 (12) :1513-1524
[7]   Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension -: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial [J].
Devereux, RB ;
Palmieri, V ;
Sharpe, N ;
De Quattro, V ;
Bella, JN ;
de Simone, G ;
Walker, JF ;
Hahn, RT ;
Dahlöf, B .
CIRCULATION, 2001, 104 (11) :1248-1254
[8]   ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618
[9]   ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[10]   PATTERNS OF LEFT-VENTRICULAR HYPERTROPHY AND GEOMETRIC REMODELING IN ESSENTIAL-HYPERTENSION [J].
GANAU, A ;
DEVEREUX, RB ;
ROMAN, MJ ;
DESIMONE, G ;
PICKERING, TG ;
SABA, PS ;
VARGIU, P ;
SIMONGINI, I ;
LARAGH, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (07) :1550-1558